$IVVD Income Statement | Understand Stock

$IVVD

$0.59 -$0.02 (3.95%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Product revenue
Total revenues
Operating expenses:
Cost of product revenue
Research and development expense
Acquired in-process research and development(2)
Acquired in-process research and development
Selling, general and administrative
Warrant expense
Total operating costs and expenses

Loss from operations
Other income:
Other income, net
Net loss
Other comprehensive income (loss)
Unrealized (loss) gain, net of tax
Comprehensive loss
Net loss per share attributable to common stockholders, basic and diluted
Weighted-average common shares outstanding, basic and diluted

Net loss per share attributable to common stockholders, basic
Net loss per share attributable to common stockholders, diluted
Weighted-average common shares outstanding, diluted
Weighted-average common shares outstanding, basic

Comments